blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2420240

EP2420240 - Azithromycin for the treatment of nodular acne [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.03.2017
Database last updated on 26.07.2024
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG		published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
Dow Pharmaceutical Sciences, Inc.
1330a Redwood Way
Petaluma CA 94954-6542 / US
[2012/08]
Inventor(s)01 / Osborne, David Wade
4215 Creekside Court
Fort Collins, CO 80525 / US
02 / Dow, Gordon Jay
4189 Chaparral Court
Santa Rosa, CA 95409 / US
03 / Chaudhuri, Bhaskar
6938 Calabazas Creek Circle
San Jose, CA 95129 / US
04 / Calvarese, Barry
463 Claremont Way
Menlo Park, CA 94025 / US
 [2012/08]
Representative(s)Teall, Charlotte, et al
Forresters IP LLP
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
[N/P]
Former [2016/19]Teall, Charlotte, et al
Forresters
Skygarden
Erika-Mann-Strasse 11
80636 München / DE
Former [2012/13]Teall, Charlotte, et al
Forrester & Boehmert
SkyGarden
Erika-Mann-Strasse 11
80636 München / DE
Former [2012/08]Teall, Charlotte
Forrester & Boehmert
Pettenkoferstrasse 20-22
80336 Munich / DE
Application number, filing date11188960.624.09.2007
[2012/08]
Priority number, dateUS20060849065P03.10.2006         Original published format: US 849065 P
US2006063512706.12.2006         Original published format: US 635127
[2012/08]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2420240
Date:22.02.2012
Language:EN
[2012/08]
Type: B1 Patent specification 
No.:EP2420240
Date:11.05.2016
Language:EN
[2016/19]
Search report(s)(Supplementary) European search report - dispatched on:EP06.12.2011
ClassificationIPC:A61K31/70, A61K31/205, A61K31/7052, A61P17/10
[2012/08]
CPC:
A61K31/7052 (EP,KR,US); A61K31/203 (KR); A61K31/205 (EP,US);
A61P17/00 (EP); A61P17/10 (EP)
C-Set:
A61K31/205, A61K2300/00 (EP,US);
A61K31/7052, A61K2300/00 (US,EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/19]
Former [2012/08]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:Azithromycin zur Behandlung von knotiger Akne[2012/08]
English:Azithromycin for the treatment of nodular acne[2012/08]
French:L'azithromycine pour le traitement de l'acné nodulaire[2012/08]
Examination procedure21.08.2012Amendment by applicant (claims and/or description)
21.08.2012Examination requested  [2012/39]
09.12.2013Despatch of a communication from the examining division (Time limit: M06)
19.06.2014Reply to a communication from the examining division
01.07.2015Despatch of a communication from the examining division (Time limit: M02)
28.08.2015Reply to a communication from the examining division
16.11.2015Communication of intention to grant the patent
23.03.2016Fee for grant paid
23.03.2016Fee for publishing/printing paid
23.03.2016Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP07838730.5  / EP2086552
Opposition(s)14.02.2017No opposition filed within time limit [2017/16]
Fees paidRenewal fee
14.11.2011Renewal fee patent year 03
14.11.2011Renewal fee patent year 04
14.11.2011Renewal fee patent year 05
20.09.2012Renewal fee patent year 06
27.09.2013Renewal fee patent year 07
29.09.2014Renewal fee patent year 08
08.09.2015Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.09.2007
AT11.05.2016
BE11.05.2016
BG11.05.2016
CY11.05.2016
DK11.05.2016
EE11.05.2016
FI11.05.2016
IS11.05.2016
LT11.05.2016
LV11.05.2016
MC11.05.2016
NL11.05.2016
RO11.05.2016
SE11.05.2016
SI11.05.2016
SK11.05.2016
TR11.05.2016
GR12.08.2016
PT12.09.2016
IE24.09.2016
LU24.09.2016
CH30.09.2016
LI30.09.2016
MT30.09.2016
[2018/38]
Former [2018/33]HU24.09.2007
AT11.05.2016
BE11.05.2016
CY11.05.2016
DK11.05.2016
EE11.05.2016
FI11.05.2016
IS11.05.2016
LT11.05.2016
LV11.05.2016
MC11.05.2016
NL11.05.2016
RO11.05.2016
SE11.05.2016
SI11.05.2016
SK11.05.2016
TR11.05.2016
GR12.08.2016
PT12.09.2016
IE24.09.2016
LU24.09.2016
CH30.09.2016
LI30.09.2016
MT30.09.2016
Former [2018/29]HU24.09.2007
AT11.05.2016
BE11.05.2016
CY11.05.2016
DK11.05.2016
EE11.05.2016
FI11.05.2016
LT11.05.2016
LV11.05.2016
MC11.05.2016
NL11.05.2016
RO11.05.2016
SE11.05.2016
SI11.05.2016
SK11.05.2016
TR11.05.2016
GR12.08.2016
PT12.09.2016
IE24.09.2016
LU24.09.2016
CH30.09.2016
LI30.09.2016
Former [2018/28]HU24.09.2007
AT11.05.2016
BE11.05.2016
CY11.05.2016
DK11.05.2016
EE11.05.2016
FI11.05.2016
LT11.05.2016
LV11.05.2016
MC11.05.2016
NL11.05.2016
RO11.05.2016
SE11.05.2016
SI11.05.2016
SK11.05.2016
GR12.08.2016
PT12.09.2016
IE24.09.2016
LU24.09.2016
CH30.09.2016
LI30.09.2016
Former [2017/41]AT11.05.2016
BE11.05.2016
DK11.05.2016
EE11.05.2016
FI11.05.2016
LT11.05.2016
LV11.05.2016
MC11.05.2016
NL11.05.2016
RO11.05.2016
SE11.05.2016
SI11.05.2016
SK11.05.2016
GR12.08.2016
PT12.09.2016
IE24.09.2016
LU24.09.2016
CH30.09.2016
LI30.09.2016
Former [2017/37]AT11.05.2016
BE11.05.2016
DK11.05.2016
EE11.05.2016
FI11.05.2016
LT11.05.2016
LV11.05.2016
MC11.05.2016
NL11.05.2016
RO11.05.2016
SE11.05.2016
SI11.05.2016
SK11.05.2016
GR12.08.2016
PT12.09.2016
IE24.09.2016
CH30.09.2016
LI30.09.2016
Former [2017/31]AT11.05.2016
BE11.05.2016
DK11.05.2016
EE11.05.2016
FI11.05.2016
LT11.05.2016
LV11.05.2016
MC11.05.2016
NL11.05.2016
RO11.05.2016
SE11.05.2016
SI11.05.2016
SK11.05.2016
GR12.08.2016
PT12.09.2016
Former [2017/11]AT11.05.2016
BE11.05.2016
DK11.05.2016
EE11.05.2016
FI11.05.2016
LT11.05.2016
LV11.05.2016
NL11.05.2016
RO11.05.2016
SE11.05.2016
SK11.05.2016
GR12.08.2016
PT12.09.2016
Former [2017/10]BE11.05.2016
DK11.05.2016
EE11.05.2016
FI11.05.2016
LT11.05.2016
LV11.05.2016
NL11.05.2016
RO11.05.2016
SE11.05.2016
SK11.05.2016
GR12.08.2016
PT12.09.2016
Former [2017/07]DK11.05.2016
FI11.05.2016
LT11.05.2016
LV11.05.2016
NL11.05.2016
SE11.05.2016
GR12.08.2016
PT12.09.2016
Former [2016/52]FI11.05.2016
LT11.05.2016
LV11.05.2016
NL11.05.2016
SE11.05.2016
GR12.08.2016
PT12.09.2016
Former [2016/51]FI11.05.2016
LT11.05.2016
LV11.05.2016
NL11.05.2016
GR12.08.2016
PT12.09.2016
Former [2016/49]FI11.05.2016
LT11.05.2016
NL11.05.2016
Former [2016/46]LT11.05.2016
Documents cited:Search[XI]  - INNOCENZI D ET AL, "Moderate acne vulgaris: Efficacy, safety and compliance of a systemic treatment with azithromycin for 12 weeks", DERMATOLOGIA CLINICA 200507 IT, (200507), vol. 25, no. 3, ISSN 0392-1395, pages 126 - 130, XP009122628 [X] 1,2,5,7,9,13 * page 128, column R, paragraph 2 * * figure 1 * [I] 1-13
 [XI]  - RAFIEI R ET AL, "Azithromycin versus tetracycline in the treatment of acne vulgaris", JOURNAL OF DERMATOLOGICAL TREATMENT 20060701 GB, (20060701), vol. 17, no. 4, pages 217 - 221, XP009122616 [X] 1,2,5,7,9,12,13 * page 218, column R, paragraph 1 * * page 220, column L, paragraph 1 * [I] 1-13
 [YD]  - FERNANDEZ-OBREGON A C, "Azithromycin for the treatment of acne", INTERNATIONAL JOURNAL OF DERMATOLOGY, INT. SOCIETY OF TROPICAL DERMATOLOGY INC.,; US HOUSTON, TX, (20000101), vol. 39, ISSN 0011-9059, pages 45 - 50, XP002213964 [YD] 1-13 * the whole document *

DOI:   http://dx.doi.org/10.1046/j.1365-4362.2000.00749.x
 [Y]  - ZOUBOULIS C C ET AL, "UPDATE AND FUTURE OF SYSTEMIC ACNE TREATMENT", DERMATOLOGY,, (20030101), vol. 206, no. 1, ISSN 1018-8665, pages 37 - 53, XP008021864 [Y] 1-13 * page 48, column L, line 2; table 6 *

DOI:   http://dx.doi.org/10.1159/000067821
by applicantUS4474766
 US4474758
 US4517359
 US6268489
 US2004147492
    - PIGATTO ET AL., "Isotretinoin versus Minocycline in Cystic Acne: A Study of Lipid Metabolism", DERMATOLOGIES, (1986), vol. 172, pages 154 - 159
    - GOLLNICK ET AL., "Comparison of Combined Azaleic Acid Cream Plus Oral Minocycline with Oral Isotretinoin in Severe Acne", EUR. J. DERMATOL., (2001), vol. 11, pages 538 - 544
    - FERNANDEZ-OBREGON, "Azithromycin for the Treatment of Acne", INTERNATIONAL JOURNAL OF DERMATOLOGY, (2000), vol. 39, pages 45 - 50
    - SINGHI, MK ET AL., "Comparison of Oral Azithromycin Pulse with Daily Doxycycline in the Treatment of Acne Vulgaris", INDIAN JOURNAL OF DERMATOLOGY, VENEREOLOGY, AND LEPROLOGY, (2003), vol. 69, no. 4, pages 274 - 276, XP009122598
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.